Bioceres Crop Solutions Corp.BIOX
| Jun 30,
2023 |
|---|
| Result for the year | 20 |
|---|
| Income tax | -1,068,652 |
|---|
| Financial results | 35 |
|---|
| Adjustments for depreciation expense | 5 |
|---|
| Amortization of intangible assets | 11 |
|---|
| Depreciation of leased assets | 4 |
|---|
| Transactional expenses | 4 |
|---|
| Adjustments for share-based payments | 3 |
|---|
| Share of profit or loss of joint ventures and associates | 1 |
|---|
| Adjustments for provisions | 221,008 |
|---|
| Loss of participation in joint ventures and associates | -133,079 |
|---|
| Allowance for impairment of trade debtors | 1 |
|---|
| Adjustments for provisions | 221,008 |
|---|
| Allowance for obsolescence | 1 |
|---|
| Allowance for impairment of trade debtors | 1 |
|---|
| Initial recognition and changes in the fair value of biological assets | -610,554 |
|---|
| Allowance for obsolescence | 1 |
|---|
| Changes in the net realizable value of agricultural products after harvest | -4,351,433 |
|---|
| Initial recognition and changes in the fair value of biological assets | -610,554 |
|---|
| Gain or loss on sale of equipment and intangible assets | -74,593 |
|---|
| Changes in the net realizable value of agricultural products after harvest | -4,351,433 |
|---|
| Gain or loss on sale of equipment and intangible assets | -74,593 |
|---|
| Trade receivables | -56,867,123 |
|---|
| Other receivables | -11,475,717 |
|---|
| Income and minimum presumed income taxes payable | -16,154,083 |
|---|
| Inventories and biological assets | 11 |
|---|
| Trade and other payables | -4,501,398 |
|---|
| Employee benefits and social security | 1 |
|---|
| Deferred revenue and advances from customers | 13 |
|---|
| Income taxes paid | -4,072,347 |
|---|
| Interest collected | 5 |
|---|
| Inflation effects on working capital adjustments | 376,597 |
|---|
| Net cash flows generated (used) by operating activities | 3 |
|---|
| Proceeds from sale of property, plant and equipment | 137,357 |
|---|
| Net cash received from business combination | 4 |
|---|
| Proceeds from financial assets | 1 |
|---|
| Investment in financial assets | 9 |
|---|
| Purchase of property, plant and equipment | 11 |
|---|
| Capitalized development expenditures | 11 |
|---|
| Purchase of intangible assets | 449,673 |
|---|
| Net cash flows (used) generated by investing activities | -25,725,670 |
|---|
| Proceeds from borrowings | 80 |
|---|
| Repayment of borrowings and financed payments | 17 |
|---|
| Interest payments | 18 |
|---|
| Other financial proceeds or payments, net | -4,767,378 |
|---|
| Other financial proceeds or payments, net | -4,767,378 |
|---|
| Leased assets payments | 4 |
|---|
| Purchase of own shares | 3 |
|---|
| Purchase of own shares | 3 |
|---|
| Leased assets payments | 4 |
|---|
| Net cash flows generated by financing activities | 33 |
|---|
| Cash dividend distributed by subsidiary | 452,129 |
|---|
| Net cash flows generated by financing activities | 33 |
|---|
| Net increase in cash and cash equivalents | 10 |
|---|
| Inflation effects on cash and cash equivalents | -101,767 |
|---|
| Effect of exchange rate changes on cash and equivalents | 5 |
|---|